GILEAD SCIENCES, INC.

Holdings History for Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Symbol: KLRS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 723,273 shares
Security Ownership %: 3.9%

Shares, Excluding Options vs Price

Value, Excluding Options

GILEAD SCIENCES, INC. ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

20 Mar 2025 - GILEAD SCIENCES, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 723,273 shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS). This represents 3.9% ownership of the company. This is the first filing by GILEAD SCIENCES, INC. disclosing ownership of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
GILEAD SCIENCES, INC.	3.9%		$4,715,740	723,273			$6.52	13G/A	18 Mar 2025	20 Mar 2025, 16:32

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0.07%	$0	0	-317,789	-100%	$10.02	Q3 2025
30 Jun 2025	0.07%	-0.08%	$848,497	317,789	-405,484	-56%	$2.67	Q2 2025
31 Mar 2025	0.49%	+0.49%	$5,807,882	723,273	+723,273	NEW	$8.03	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.